Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
Agency: National Institutes of Health
- 93.853 -- Extramural Research Programs in the Neurosciences and Neurological Disorders
Closed opportunityLast Updated: May 13, 2026
Important dates
- Closed: November 10, 2026
Award details
- Expected project funding: $40,000,000
- Expected awards: 4
Award min.
Not specified
Award max.
Not specified
- Funding opportunity number:RFA-NS-26-001
- Cost sharing or matching requirement:No
- Funding instrument type:
- Cooperative agreement
- Opportunity Category:Discretionary
- Opportunity Category Explanation:Not specified
- Category of Funding Activity:
- Health
- Category Explanation:Not specified
History
- Posted date: May 4, 2026
- Archive date: January 10, 2027
- Version: 1
Summary
Jump to documentsEligibility
Business
- Small businesses
- For-profit organizations other than small businesses
Government
- Federally recognized Native American tribal governments
- County governments
- State governments
- Special district governments
- Public and Indian housing authorities
- City or township governments
Education
- Private institutions of higher education
- Independent school districts
- Public and state institutions of higher education
Nonprofit
- Other Native American tribal organizations
- Nonprofits non-higher education without 501(c)(3)
- Nonprofits non-higher education with 501(c)(3)
Miscellaneous
- Other
Additional information on eligibility
Documents
| File name | Description | Last updated |
|---|---|---|
| RFA-NS-26-001-Full-Announcement.html | RFA-NS-26-001-Full-Announcement.html | May 4, 2026 03:56 PM UTC |
Agency contact information
Email: NINDSALSMailbox@mail.nih.gov
NINDSALSMailbox@mail.nih.gov
Link to additional information
No additional information is available
